The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review

L E Kristensen, R Christensen, H Bliddal, P Geborek, B Danneskiold-Samsøe, T Saxne

    51 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review'. Sammen danner de et unikt fingeraftryk.

    Medicin og biovidenskab